Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.

Arnold, Markus; Schweizer, Juliane; Nakas, Christos T; Schütz, Valerie; Westphal, Laura P; Inauen, Corinne; Pokorny, Thomas; Luft, Andreas; Leichtle, Alexander; Arnold, Marcel; Bicvic, Antonela; Fischer, Urs; De Marchis, Gian Marco; Bonati, Leo H; Müller, Mandy D; Kahles, Timo; Nedeltchev, Krassen; Cereda, Carlo W; Kägi, Georg; Bustamante, Alejandro; ... (2021). Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study. European heart journal, 42(22), pp. 2186-2196. Oxford University Press 10.1093/eurheartj/ehab081

[img] Text
Arnold__Lipoproteina_is_associated_with_large_artery_atherosclerosis_stroke_aetiology.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

AIMS

Lipoprotein(a) [Lp(a)] is a recognized causal risk factor for atherosclerotic cardiovascular disease but its role for acute ischaemic stroke (AIS) is controversial. In this study, we evaluated the association of Lp(a) with large artery atherosclerosis (LAA) stroke and risk of recurrent cerebrovascular events in AIS patients.

METHODS AND RESULTS

For this analysis of the prospective, observational, multicentre BIOSIGNAL cohort study we measured Lp(a) levels in plasma samples of 1733 primarily Caucasian (98.6%) AIS patients, collected within 24 h after symptom onset. Primary outcomes were LAA stroke aetiology and recurrent cerebrovascular events (ischaemic stroke or transient ischaemic attack) within 1 year. We showed that Lp(a) levels are independently associated with LAA stroke aetiology [adjusted odds ratio 1.48, 95% confidence interval (CI) 1.14-1.90, per unit log10Lp(a) increase] and identified age as a potent effect modifier (Pinteraction =0.031) of this association. The adjusted odds ratio for LAA stroke in patients aged <60 years was 3.64 (95% CI 1.76-7.52) per unit log10Lp(a) increase and 4.04 (95% CI 1.73-9.43) using the established cut-off ≥100 nmol/l. For 152 recurrent cerebrovascular events, we did not find a significant association in the whole cohort. However, Lp(a) levels ≥100 nmol/l were associated with an increased risk for recurrent events among patients who were either <60 years [adjusted hazard ratio (HR) 2.40, 95% CI 1.05-5.47], had evident LAA stroke aetiology (adjusted HR 2.18, 95% CI 1.08-4.40), or had no known atrial fibrillation (adjusted HR 1.60, 95% CI 1.03-2.48).

CONCLUSION

Elevated Lp(a) was independently associated with LAA stroke aetiology and risk of recurrent cerebrovascular events among primarily Caucasian individuals aged <60 years or with evident arteriosclerotic disease.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Nakas, Christos T., Leichtle, Alexander Benedikt (B), Arnold, Marcel, Bicvic, Antonela, Fischer, Urs Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1522-9645

Publisher:

Oxford University Press

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

30 Sep 2021 14:49

Last Modified:

02 Mar 2023 23:35

Publisher DOI:

10.1093/eurheartj/ehab081

PubMed ID:

33709115

Uncontrolled Keywords:

Acute ischaemic stroke Large artery atherosclerosis Lipoprotein(a)

BORIS DOI:

10.48350/159334

URI:

https://boris.unibe.ch/id/eprint/159334

Actions (login required)

Edit item Edit item
Provide Feedback